Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting to the ambulatory setting.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Non-pregnant adults, ages greater than or equal to 18 years, admitted to VUMC

• Able to give informed consent

• Hyperglycemia requiring insulin therapy including subcutaneous insulin injection or continuous subcutaneous insulin infusion (patient's own insulin pump) during hospitalization and at the time of discharge

• POC glucose or venous glucose levels in the 24 hours prior to participation need to be 70-350 mg/dL

• Need glucose readings greater than or equal to one time per day

• Mental status and dexterity adequate to use Libre 3 Plus or Dexcom G7 sensors with Libre 3 or Dexcom G7 application on patient's smartphone

Locations
United States
Tennessee
Vanderbilt University Medical Center
RECRUITING
Nashville
Contact Information
Primary
Angel Morvant, MD
angel.morvant@vumc.org
615-343-8332
Time Frame
Start Date: 2025-03-09
Estimated Completion Date: 2026-01
Participants
Target number of participants: 60
Treatments
Experimental: Libre 3 Plus Continuous Glucose Monitor
Subjects in this arm will start using the Libre 3 Plus continuous glucose monitor.
Experimental: Dexcom G7 Continuous Glucose Monitor
Subjects in this arm will start using the Dexcom G7 continuous glucose monitor.
Sponsors
Leads: Vanderbilt University Medical Center

This content was sourced from clinicaltrials.gov